Project Grant HT94252510233
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Defense Health Agency awarded a $610,656 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The grant, effective March 1, 2025 through February 29, 2028, is for research to decipher epigenetic mechanisms that dictate poor responses to KRAS inhibition in lung cancer. As a prominent academic research institution, Columbia University will...
This federal Project Grant award of $1,645,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at The Trustees of Columbia University in the City of New York to treat HER2 therapy-resistant brain metastasis using antidepressants. The award, with a period of performance from July 1, 2025 to June 30, 2028, will fund innovative biomedical research at the university's Health Sciences Division to investigate...
The Trustees of Columbia University in the City of New York received a three-year, $729,000 Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this award, Columbia University will conduct research from March 2021 to February 2024 to decipher the mechanisms that drive breast...
The Trustees of Columbia University in New York City will receive $486,000 under a two-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research into novel regulators of lineage plasticity in castration-resistant prostate cancer. Through this funding, Columbia University researchers will investigate medical solutions for prostate cancer that persists despite hormone therapy, with the goal of transforming...
This $1,644,999.00 Project Grant award was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The grant funds research on "The Role of Streptococcus in Esophageal Neoplasia" over the period from July 1, 2025 to June 30, 2028. As a prominent academic research institution, Columbia University will leverage...
The Trustees of Columbia University in New York City will receive $567,000 from the Department of the Army Medical Command under a three-year Project Grant award to identify epigenetic vulnerabilities in peripheral T-cell lymphomas. The grant period runs from September 1, 2022 through August 31, 2025. The funding supports research conducted under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
The Trustees of Columbia University in New York City will receive $539,460 under a three-year Project Grant award from the Department of the Army Medical Command to investigate B7-H3 (CD276) as a therapeutic target in lethal prostate cancers. The grant was awarded on May 15, 2021 with a completion date of May 14, 2024. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to...
The Trustees of Columbia University in the City of New York (Columbia University) was awarded a $658,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 targeting inflammatory signals as therapeutic strategies for peripheral T-cell lymphoma. Through this award, Columbia University will investigate medical solutions for lymphoma, a type of cancer...
The Trustees of Columbia University in New York City will receive $729,000 from the Department of the Army Medical Command under a three-year Project Grant award titled "Eliminating Minimal Residual Disease After Targeted Therapy in Breast Cancer." The grant is part of the Military Medical Research and Development program administered by the agency, with a focus on transforming health care for service members and the public through innovative biomedical research. Under the award,...